stockrowICON PLC
ICLR Healthcare Diagnostics & Research
ICON PLC’s revenue for fiscal 2025 (year ended December 2025) was $8.3 billion, up 0.76% from fiscal 2024.
- Revenue
- −2.86%
- EPS
- +143.2%
- Free cash flow
- −8.01%
- Total debt
- −0.86%
Quarter to September 2026, against a year earlier
Follow ICLR
Alert me
ICON PLC (ICLR) Free cash flow
ICON PLC's free cash flow for fiscal 2025 was $862.0M, down 22.9% from $1.1B in fiscal 2024. Over the twelve months to 30 September 2026 it was $857.1M. Over the past ten years it has ranged from $216.6M (fiscal 2016) to $1.1B (fiscal 2024); the current reading is higher than 82% of that period. ICON PLC ranks 10th of 49 Diagnostics & Research companies by free cash flow.
Free cash flow, annual
Embed this chart
Annual newest first
| Period | Free cash flow | Change |
|---|---|---|
| FY2025 | $862.0M | (22.94%) |
| FY2024 | $1.1B | 9.63% |
| FY2023 | $1.0B | 142.27% |
| FY2022 | $421.2M | (42.73%) |
| FY2021 | $735.4M | 39.50% |
| FY2020 | $527.2M | 45.66% |
| FY2019 | $361.9M | 64.32% |
| FY2018 | $220.2M | (34.91%) |
| FY2017 | $338.4M | 56.21% |
| FY2016 | $216.6M | (5.55%) |
Quarterly newest first
| Period | Free cash flow | Change |
|---|---|---|
| Sep 2026 | $307.1M | 28.60% |
| Jun 2026 | $238.8M | 75.32% |
| Mar 2026 | $136.2M | (22.08%) |
| Dec 2025 | $174.8M | (47.64%) |
| 43 more quarters | Free account |
Against its own ten years
Free cash flow against peers
| Company | Free cash flow |
|---|---|
| DGX Quest Diagnostics Incorporated compare | $1.4B |
| LH Labcorp Holdings Inc. compare | $1.3B |
| ILMN Illumina, Inc. compare | $1.1B |
| ICLR ICON PLC | $857.1M |
| MEDP Medpace Holdings, Inc. compare | $667.6M |
| RVTY Revvity Inc. compare | $602.5M |
| QGEN QIAGEN N.V. compare | $440.6M |
| CRL Charles River Laboratories International, Inc. compare | $399.6M |
| GH Guardant Health, Inc. compare | −$232.1M |
What Free cash flow is
Free Cash Flow tells an investor how much cash a company’s operations generate after paying for its investment in physical and intangible assets.
Operating Cash Flow + Property, Plant, Equipment Change (Net) + Intangible Assets Change (Net)
More on ICLR
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement